Tradestie Institutional Equity Comparison Engine
SBEV vs KTTA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
KTTA Overall Edge
KTTA Captures Institutional Edge (3โ0 Pillars ยท 5โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Pasithea Therapeutics Corp. Common Stock (KTTA) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, SBEV trades at N/M Forward P/E with -23888.5% operating margin (-93.8% YoY revenue) versus KTTA at N/M Forward P/E and 0.0% operating margin (+1498.1% YoY). In options structure, SBEV sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against KTTA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
SBEV N/M vs KTTA N/M Fwd P/E
Growth & Margin Winner
KTTA
Op Margin -23888.5% vs 0.0% ยท YoY -93.8% vs +1498.1%
Momentum & Technical Winner
KTTA
1Y -73.4% vs +0.6% ยท 52W Pos 12% vs 11%
Options & Structure Winner
KTTA
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
SBEV
NYSE American
Splash Beverage Group, Inc.
Beverages
$0.47
+10.94% 1D
Market Cap
$2.7M
1M Return
+358.21%
1Y Return
-73.38%
Forward P/E
N/M
Unified AI Score
36.4 / 100
SELL
Tech 15.0
Fund 32.0
Flow 44.0
Mom 40.0
KTTA
NASDAQ
Pasithea Therapeutics Corp. Common Stock
Pharmaceutical Preparations
$0.48
-0.48% 1D
Market Cap
$17.7M
1M Return
+7.52%
1Y Return
+0.59%
Forward P/E
N/M
Unified AI Score
42.1 / 100
HOLD
Tech 20.0
Fund 40.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SBEV -73.38%
KTTA +0.59%
Spread: +61.13 pp (KTTA Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | SBEV Revenue | KTTA Revenue | SBEV Op. Margin | KTTA Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $0M | N/A | 5.1% | N/A | SBEV |
| FY2019 | $0M | N/A | -22009.4% | N/A | SBEV |
| FY2020 | $0M | N/A | -767.9% | N/A | SBEV |
| FY2021 | $10M | $0M | -257.0% | -29925.7% | SBEV |
| FY2022 | $20M | $0M | -118.3% | -2587.3% | SBEV |
| FY2023 | $20M | N/A | -81.1% | N/A | SBEV |
| FY2024 | $0M | N/A | -1235.6% | N/A | SBEV |
| FY2025 | $0M | N/A | -19415.6% | N/A | SBEV |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SBEV | KTTA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $2.7M | $17.7M | Larger Scale | KTTA |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -93.8% | +1498.1% | Higher Growth | KTTA |
| Operating Margin (TTM) Profitability | -23888.5% | 0.0% | Higher Margin | KTTA |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -1130.2% | -88.8% | Higher ROE | KTTA |
| 52-Week Range Position Momentum | 12% ($0โ$3) | 11% ($0โ$2) | Stronger Trend | SBEV |
| Beta / 30D Volatility Risk Regime | -1.41ฮฒ ยท 136% Vol | 0.68ฮฒ ยท 185% Vol | Lower Realized Risk | SBEV |
| Unified Institutional Score Composite Signal | 36.4 / 100 (SELL) | 42.1 / 100 (HOLD) | Higher Composite | KTTA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SBEV vs KTTA Buy Guide
SBEV
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
KTTA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SBEV nor KTTA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.